• Most Popular
  • Most Shared

Dr. Reddy's gets tentative US OK for pantoprazole

Sun Dec 23, 2007 11:16pm EST

Stocks

   

Stocks

MUMBAI, Dec 24 (Reuters) - India's Dr. Reddy's Laboratories Ltd (REDY.BO)(RDY.N) has received tentative approval from the U.S. Food and Drug Administration for heartburn drug pantoprazole sodium in the extended release tablet format, the regulator's Web site showed.

(Reporting by Rina Chandran; Editing by John Mair)

((rina.chandran@reuters.com; +91 22 6636 9251; Reuters Messaging: rina.chandran.reuters.com@reuters.net)) Keywords: REDDYS FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM261603
Stocks


More from Reuters

Photo

Obama blames "systemic failures" for plane attack

KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed "human and systemic failures" for allowing a botched Christmas Day attack aboard a Detroit-bound airliner and a U.S. official said the incident was linked to al Qaeda. | Video

» More Top News
A man passes by a logo of the Tokyo Stock Exchange at the bourse in Tokyo December 29, 2009. REUTERS/Yuriko Nakao

Toyko trade gets turbocharged

The "Arrowhead" gives Asia's largest -- and long derided -- bourse a viable electronic trading platform, it hopes.  Full Article 

Global Markets
REUTERS/James Saft
JAMES SAFT:

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary 

COMMENTARY